Class Action Lawsuit Over Belviq Cancer Risk Dismissed By NY Judge
A federal judge has dismissed a Belviq cancer class action lawsuit for failing to make adequate claims of injury against the recalled weight loss drug's manufacturers.
A federal judge has dismissed a Belviq cancer class action lawsuit for failing to make adequate claims of injury against the recalled weight loss drug's manufacturers.
Three drug manufacturers are calling for a Belviq class action lawsuit to be dismissed, saying the charges are not applicable under New York laws.
A class action lawsuit filed against the makers of Belviq claim they knew about the cancer risks of the recalled weight loss drug before it even hit the market.
Thousands of Belviq users face an increased cancer risk due to the side effects of the recalled weight loss drug.